Greenstone intros authorized Relpax generic

PEAPACK, N.J. — Pfizer subsidiary Greenstone  recently announced the introduction of its authorized generic of Relpax (eletriptan hydrobromide) tablets. The drug is indicated to treat migraine headaches.

Greenstone’s authorized generic will be available in 20- and 40-mg dosage strengths in blister packs of six tablets per card.